Activate your free access to EVID AI

Welcome to EVID AI! You have been approved to receive FREE access to the platform through 2026, subject to terms and conditions. To activate your access, please complete the form below. We'll then follow up with further guidance. Thank you for your interest.

Activate your EVID AI access and complete setup

You’ve been approved for access to EVID AI. Please complete the details below to confirm your intended use, support requirements, and acceptance of our terms and conditions.

Project Context

Which therapeutic area, method, or disease area are you focused on?

Activation Code(Required)

This should auto-populated if you clicked the link in your email. If it didn't please copy and paste the code.

Email(Required)

This should auto-populated if you clicked the link in your email. If it didn't please use the same email that you received the activation code in.

Is your intended use tied to a specific asset, product, indication, or portfolio?(Required)

If yes, please briefly describe the asset, indication, or decision context

What is the expected timing of your evidence need?(Required)

Operating Model

Do you currently use another evidence synthesis or literature review platform?(Required)

Would you like a complimentary training session to support onboarding?(Required)

Will you need enterprise capabilities such as SSO, custom workflows, or organisation-level administration?(Required)

Terms and Acknowledgement

Required

Requesting access consent(Required)

By requesting access, I acknowledge that EVID AI is designed to support literature searching, screening, evidence organisation, and evidence synthesis workflows. I understand that any outputs generated by the platform must be reviewed by appropriately qualified professionals before being used in formal deliverables, publications, payer or HTA submissions, regulatory materials, medical communications, or other external decision-making.

Agree not to enter confidential info(Required)

I agree not to upload or enter any confidential, proprietary, patient-identifiable, personal health, or other sensitive information into EVID AI unless expressly authorised under a separate written agreement with Genesis Research Group and permitted by applicable law.

Confirm I have the authority(Required)

I confirm that I have the authority to provide any information or materials that I upload to the platform.

Agree to participate in surveys(Required)

Genesis Research Group may invite me to provide feedback on my experience using EVID AI. Unless otherwise agreed in writing, participation in surveys or feedback activities is voluntary, and any feedback shared externally will be anonymised.

EVID AI Trial Terms Acknowledgement(Required)

I acknowledge and agree to the EVID AI Trial Terms.

Optional

I confirm that I am authorised to grant this permission on behalf of my organisation, and I agree that Genesis Research Group may use my organisation’s name and logo solely to identify it as a user of EVID AI in Genesis Research Group presentations, proposals, and case studies. Genesis Research Group will not state or imply endorsement without separate written consent.

I Authorize Use of Name and Logo

I authorise Genesis Research Group to use my organisation’s name and logo as described above.

Genesis Research Group - ISPOR corporate partner

Headquarters:

HOBOKEN
221 River Street, 9th Floor
Hoboken, New Jersey 07030, US